Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) Non-Current Assets (2020 - 2024)

RAPT Therapeutics' Non-Current Assets history spans 5 years, with the latest figure at $5.9 million for Q3 2024.

  • For Q3 2024, Non-Current Assets fell 53.37% year-over-year to $5.9 million; the TTM value through Sep 2024 reached $31.6 million, down 40.66%, while the annual FY2023 figure was $11.5 million, 14.56% down from the prior year.
  • Non-Current Assets for Q3 2024 was $5.9 million at RAPT Therapeutics, down from $6.7 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $13.7 million in Q1 2023 and bottomed at $3.0 million in Q3 2021.
  • The 5-year median for Non-Current Assets is $6.7 million (2024), against an average of $7.9 million.
  • The largest annual shift saw Non-Current Assets soared 290.8% in 2022 before it tumbled 53.37% in 2024.
  • A 5-year view of Non-Current Assets shows it stood at $3.4 million in 2020, then surged by 67.99% to $5.7 million in 2021, then skyrocketed by 138.65% to $13.5 million in 2022, then dropped by 14.56% to $11.5 million in 2023, then crashed by 49.19% to $5.9 million in 2024.
  • Per Business Quant, the three most recent readings for RAPT's Non-Current Assets are $5.9 million (Q3 2024), $6.7 million (Q2 2024), and $7.5 million (Q1 2024).